The generation of high-titer, helper-free retroviruses by transient transection has been achieved by using the highy transfectable 293T cell line into which are stably introduced constructs that express retroviral packaging functions. The resulting ecotropic virus packing cell line BOSC 23 produces infectious retrovirus at >106 infectious units/ml of supernatant within 72 hr after CaPO4-mediated btansfection. A stringent assay for replication-competent virus showed that no helper virus was present. The system can produce high titers of retroviral vectors expressing genes that are extremely difficult to propagate at high titer in stable producer lines. This method should facilitate and extend the use of helper-free retroviral gene transfer, as weli as be useful for gene therapy. (B-galactosidase (3-gal) expression is directed by the viral promoter in the long terminal repeat and the neomycin resistance cassette is deleted], pCRIPenv-(6), pCRIPgag-2 (6), MFG-lacZ (7), MFG-tPA [similar to MFGlacZ, but expressing the human tissue plasminogen activator gene in place of (-gal (7)], pZAP (8), pSV2Hgm (9), pGPT2E (10), pGD (11), pGDv-abi (12), and pGD210bcr/abl (11).
tion. A stringent assay for replication-competent virus showed that no helper virus was present. The system can produce high titers of retroviral vectors expressing genes that are extremely difficult to propagate at high titer in stable producer lines. This method should facilitate and extend the use of helper-free retroviral gene transfer, as weli as be useful for gene therapy.
Present methods for creating high-titer, helper-free retroviral stocks employ the creation of a stable producer cell line that expresses the retroviral vector (1) . Producer lines are made by introducing the retroviral vector into a packaging cell line, which synthesizes all the proteins required for viral assembly. It is then necessary to screen many clones for one clone that expresses the retroviral vector at high titer, because virus production by the original pool of transfected clones is low. Selection takes at least 1 month, and prolonged high expression of the retroviral mRNA may slow the growth of the producer line, allowing outgrowth of poorly producing variants during prolonged cultivation.
To circumvent these problems, a strategy was devised that uses transient transfection ofthe retroviral packaging cell line BOSC 23 to produce high-titer, helper-free infectious retroviruses. The BOSC 23 producer cell line (derived from the Ad5-transformed human embryonic kidney 293 cell line) is more transfectable than the currently employed packaging cell lines. By using BOSC 23 (8) , pSV2Hgm (9) , pGPT2E (10), pGD (11), pGDv-abi (12) , and pGD210bcr/abl (11) .
Enzymatic Assays and Nudeic Acid Prdures. Staining for (3-gal activity in intact cells and spleen was performed as described (13) . Reverse transcriptase (RT) activity was assayed in the culture medium ofexponentially growing cells as described by Goff et al. (14) . The (17) . The cells were then returned to the 37°C incubator (5% C02) for 24 hr. Subsequently, the medium was changed to 3 ml offresh 10%o FCS, and 24-48 hr later, the medium was removed and either filtered through a 0.45-,m filter or centrifuged at 500 x g for 5 min in a Sorvall RT6000B centrifuge. In experiments with chloroquine, the medium was changed to 10% FCS at 10 hr posttransfection and changed a second time at 24 hr posttransfection. Infections were performed as described (6) . Viral (6) (Fig. 1) . pCRIPenv-contains a mutation in the envelope region and expresses both gag and pol products (6) . pCRIPgag-2 contains mutations in the gag region and expresses only the ecotropic envelope (6) . In addition, both plasmids were deleted for the packaging site, and the 3' long-terminal repeat was replaced by an SV40 poly(A) site (6) . With these multiple changes, more than two crossover events are required for the generation of helper virus, even with the use of vectors containing packaging sites extending into gag, such as MFG (6) . To create the helper-free packaging cell line, it was decided to introduce the pCRIPenv-and pCRIPgag-2 constructs one after the other, rather than simultaneously, to decrease the risk of recombination and production of replication-competent virus (6). (Table 1 and W.S.P., unpublished data), it appeared that gpt selection might be necessary for maintenance of the high-titer phenotype of this subline. To test this hypothesis, passage 2 cells of the BARTLETT 96 line were thawed and cloned by limiting dilution, either in the presence or absence of gpt selection. For these experiments, MFG-lacZ, a f-galexpressing retroviral vector containing an extended retrovirus RNA packaging site was used in the transfection assay (7). After transfection ofthe BARTLETT 96 cells, this vector produced infectious retroviral stocks with titers 2-fold higher than pBND 8, which does not contain the extended packaging site (W.S.P., unpublished data). Twenty-two clones maintained in gpt selection medium were analyzed, and 7 of these clones had titers greater than 106/ml. Of these 7 clones, the clone producing the highest titer, BOSC 23, gave a titer of 2.9 x 106/ml (Table 1) . BOSC 23, used in all subsequent experiments, was maintained in gpt selective medium, and its viral titer remained stable for at least 14 passages (Table 1) .
Chloroquine Treatment of BOSC 23 Cells Doubles the Infectious Titer. To maximize the infectious titer, several modifications were made to the CaPO4 transfection protocol. Growing the BOSC 23 line in 10%o FCS with 25 p,M chloroquine for the initial 10 hr of transfection resulted in a 2-to 3-fold increase in titer (Table 1) . This is presumably due to the lysozomal neutralizing activity of the chloroquine (16) . Doubling the volume of all transfection reagents also appeared to result in a slightly higher transfection efficiency ( (4)] (Fig. 4A) . Similarly, P210 was immunoprecipitated from pGD210bcr/abl-infected 3T3 cells, and the protein was identical in size to the P210 product ofthe 210W cell line (5), a cell line expressing P210b-cr/al (Fig. 4B) .
Tests for Replication-Competent Virus. To test for the production of replication-competent virus, the BAG indicator cell line was used (3). This cell line contains an integrated (-gal provirus capable ofbeing rescued by either helper virus or retroviral packaging functions and is able to detect infectious replication-competent retrovirus in 1 ml of supernatant from a known retroviral producer line at dilutions up to 5 x 106/ml (W.S.P., unpublished data). BAG cells were infected with 1 ml of viral supernatant from pGD (G418 titer: 3.9 x 106/ml), pGDv-abl (G418 titer: 2.9 x 106/ml), or MFG-tPA (not titered; however, MFG-lacZ transfected in parallel had a titer of 7 x 106/ml). Cells were split every 2-3 days at 1:10, and 3 ml of supernatant was used to infect 3T3 cells after infection) were infected with 1 ml ofundiluted 48-hr supernatant from either pGDabl-transfected BOSC 23 cells (A) or pGD-transfected BOSC 23 cells (B) as described in Materials and Methods. G418R titers for these stocks were 2.9 x 106/ml (pGDv-abl) and 3.9 x 106/ml (pGD). Corresponding focus-forming titers were 2.1 x 106/ml for the pGDv-abl stock and <104/ml for the pGD stock. Photos were taken 48 hr after infection. Forty-eight hours posttransfection, 1 ml of the supernatant was used to infect NIH 3T3 cells, and 48 hr later, the cells were extracted and precipitated with anti-abl antiserum (pEX4) as described in ref. 15 To test the hypothesis that simultaneous introduction of the two plasmids encoding the gag-pol and env functions would produce replication-competent virus by recombination, pCRIPenv-, pCRIPgag-2, and pBND 8 were cotransfected into 293T/17 cells, and 48 hr later, 1 (24) .
Cotransfection of 293T/17 cells with pCRIPenv-, pCRIPgag-2, and pBND, which contain the same region of homology as in the COS-based system but requires more than two recombination events to generate helper virus, results in replication-competent virus. While we would not have anticipated the observed absence of helper virus in the COSbased system, one possible explanation is that COS cells recombine unintegrated DNA less frequently than 293 cells.
The BOSC 23 cell line should have many applications. These include testing the efficacy of different retroviral vectors and conditions, overexpressing proteins, and creating animal models of disease. The present work also suggests that an amphotropic counterpart to the BOSC 23 cell line may be useful in human gene therapy.
